1.A Survey of the relationships between outcomes from therapy and patients background in the therapy of smoking cessation
Hiroko Horie ; Takanori Nakamura ; Shigetaka Kuroki ; Naofumi Ono ; Takahisa Eguchi ; Atsushi Kinoshita ; Gisho Honda ; Fusao Komada
Japanese Journal of Drug Informatics 2010;11(3):180-188
Purpose: With the aim of improving the efficiency of smoking cessation treatment, we analyzed and classified various factors to identify the relationships between the background of patients and effects of treatment, and examine their characteristics.
Methods: We conducted a questionnaire survey to collect information on the situation of patients, and obtained their treatment data from medical records. Decision tree analysis, a data mining method, was employed to examine these data.
Results: According to the results of the survey, the smoking cessation rate was 80.4%. The rate was associated with CO concentrations in the breath at the initial examination, nicotine content in cigarettes smoked by patients, and the daily and total number of cigarettes smoked. The smoking cessation rate among patients under emotional stress was 76.2%; the rate was higher when patients were able to reduce their mental stress levels.
Conclusion: We identified characteristic relationships between the background of patients and the effects of treatment, and they proved to be useful for the improvement of the smoking cessation rate.
2.Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Keisuke YAMASAKI ; Jun HATA ; Tomomi IDE ; Takuya NAGATA ; Satoko SAKATA ; Daigo YOSHIDA ; Takanori HONDA ; Yoichiro HIRAKAWA ; Toshiaki NAKANO ; Takanari KITAZONO ; Hiroyuki TSUTSUI ; Toshiharu NINOMIYA
Environmental Health and Preventive Medicine 2021;26(1):47-47
BACKGROUND:
Epidemiological evidence has shown that serum N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations, a diagnostic biomarker for heart failure, are positively associated with cardiovascular risk. Since NT-proBNP in serum is excreted in urine, it is hypothesized that urinary NT-proBNP concentrations are correlated with serum concentrations and linked with cardiovascular risk in the general population.
METHODS:
A total of 3060 community-dwelling residents aged ≥ 40 years without history of cardiovascular disease (CVD) were followed up for a median of 8.3 years (2007-2015). Serum and urinary concentrations of NT-proBNP at baseline were compared. The hazard ratios (HRs) and their 95% confidence intervals (CIs) for the association between NT-proBNP concentrations and the risk of developing CVD were computed using the Cox proportional hazards model.
RESULTS:
The median values (interquartile ranges) of serum and urinary NT-proBNP concentrations at baseline were 56 (32-104) pg/mL and 20 (18-25) pg/mL, respectively. There was a strong quadratic correlation between the serum and urinary concentrations of NT-proBNP (coefficient of determination [R
CONCLUSIONS
The present study demonstrated that urinary NT-proBNP concentrations were well-correlated with serum concentrations and were positively associated with cardiovascular risk. Given that urine sampling is noninvasive and does not require specially trained personnel, urinary NT-proBNP concentrations have the potential to be an easy and useful biomarker for detecting people at higher cardiovascular risk.
Adult
;
Aged
;
Aged, 80 and over
;
Biomarkers/urine*
;
Cardiovascular Diseases/urine*
;
Female
;
Heart Failure/diagnosis*
;
Humans
;
Incidence
;
Japan/epidemiology*
;
Male
;
Middle Aged
;
Natriuretic Peptide, Brain/urine*
;
Peptide Fragments/urine*
;
Prospective Studies
;
Risk Assessment